scispace - formally typeset
Open AccessJournal ArticleDOI

Robustness of gut microbiota of healthy adults in response to probiotic intervention revealed by high-throughput pyrosequencing

Reads0
Chats0
TLDR
Investigating effects of probiotics on human intestinal microbiota using 454 pyrosequencing of bacterial 16S ribosomal RNA genes with an improved quantitative accuracy suggests robustness of the gut microbiota composition in healthy adults on probiotic administration.
Abstract
Probiotics are live microorganisms that potentially confer beneficial outcomes to host by modulating gut microbiota in the intestine. The aim of this study was to comprehensively investigate effects of probiotics on human intestinal microbiota using 454 pyrosequencing of bacterial 16S ribosomal RNA genes with an improved quantitative accuracy for evaluation of the bacterial composition. We obtained 158 faecal samples from 18 healthy adult Japanese who were subjected to intervention with 6 commercially available probiotics containing either Bifidobacterium or Lactobacillus strains. We then analysed and compared bacterial composition of the faecal samples collected before, during, and after probiotic intervention by Operational taxonomic units (OTUs) and UniFrac distances. The results showed no significant changes in the overall structure of gut microbiota in the samples with and without probiotic administration regardless of groups and types of the probiotics used. We noticed that 32 OTUs (2.7% of all analysed OTUs) assigned to the indigenous species showed a significant increase or decrease of � 10-fold or a quantity difference in >150 reads on probiotic administration. Such OTUs were found to be individual specific and tend to be unevenly distributed in the subjects. These data, thus, suggest robustness of the gut microbiota composition in healthy adults on probiotic administration.

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

Two FOXP3 + CD4 + T cell subpopulations distinctly control the prognosis of colorectal cancers

TL;DR: Depletion of FOXP3hi Treg cells from tumor tissues, which would augment antitumor immunity, could thus be used as an effective treatment strategy for CRCs and other cancers, whereas strategies that locally increase the population ofFOXP3lo non-Treg cells could be used to suppress or prevent tumor formation.
Journal ArticleDOI

Dysbiosis in the gut microbiota of patients with multiple sclerosis, with a striking depletion of species belonging to clostridia XIVa and IV clusters

TL;DR: Analysis of the bacterial 16S ribosomal RNA (rRNA) gene by using a high-throughput culture-independent pyrosequencing method provided evidence of a moderate dysbiosis in the structure of gut microbiota in patients with MS, and phylogenetic tree analysis revealed that many of the clostridial species associated with MS might be distinct from those broadly associated with autoimmune conditions.
References
More filters
Journal ArticleDOI

The Genome Sequencer FLX System--longer reads, more applications, straight forward bioinformatics and more complete data sets.

TL;DR: The Genome Sequencer FLX System (GS FLX), powered by 454 Sequencing, is a next-generation DNA sequencing technology featuring a unique mix of long reads, exceptional accuracy, and ultra-high throughput.
Journal ArticleDOI

Probiotic and Gut Lactobacilli and Bifidobacteria: Molecular Approaches to Study Diversity and Activity

TL;DR: Bacterial genomics of lactobacilli and bifidobacteria is initiating the identification and validation of specific effector molecules that mediate host health effects, anticipated to dramatically alter the scope and impact of the probiotic field.
Journal ArticleDOI

The human intestinal microbiome: a new frontier of human biology.

TL;DR: Through metagenomic analysis, it is now possible to comprehensively explore the genetic nature of the intestinal microbiome, the mutually interacting system comprising the host cells and the residing microbial community.
Journal ArticleDOI

Probiotics and health: an evidence-based review.

TL;DR: This review summarizes the current knowledge on probiotics and discusses both limitations and acquired evidence to support their use in preventive and therapeutic medicine.
Journal ArticleDOI

Probiotics and gastrointestinal disease: successes, problems and future prospects.

TL;DR: Various strategies whereby probiotics may be engineered to create designer probiotics are discussed, including a receptor mimicry strategy to create probiotics that target specific pathogens and toxins and a patho-biotechnology approach using pathogen-derived genes to create more robust probiotic stains with increased host and processing-associated stress tolerance profiles.
Related Papers (5)

Structure, function and diversity of the healthy human microbiome

Curtis Huttenhower, +253 more
- 14 Jun 2012 -